Research assistance

We can help you find what you need. Call us or write us:
US: 800.298.5699
Int'l: +1.240.747.3093
Need help in your search?
 

Matching geography

Reports matching your search in:
 
 

Join Alert Me now!

Receive bi-weekly email alerts on new market research

Sign up today!
 

Drug Delivery: market research reports

1594

How a drug is delivered is a great focus of medicine today. The oral drug delivery market is the largest segment of the total drug delivery market and it is the oldest. It is also the preferred method of administering medications by both healthcare personnel and patients. The oral drug delivery market is segmented into five main categories.
  • Controlled-release/sustained-release formulations
  • Delayed-release and modified-release formulations
  • Pulsatile-release formulations
  • Taste-mask formulations
  • Microemulsion and other formulations

However, not all drugs can be delivered orally.

Therefore injection through needle or through needle-free jet delivery, pulmonary (respiratory / lung), transdermal (under the skin) are valid delivery options and are being used with many of the new drug therapies available.

As drugs get more complex, the delivery mechanisms are also become more complicated. Biopharmaceutical therapies will require different drug mechanisms. Reports in this section address the ways of delivering drugs and the market impact of those systems.

RSS Feeds

Drug Delivery market research reports and industry analysis

< prev 1  2  3  4  5  6  7  8  9  10  next >
United States Oncology Drug Delivery Preferences and Opportunities in Cancer Drug Delivery
11/2/2012 | published by: Frost & Sullivan
... home. This is important for biotechnology products used in this area as companies seek to design new products and evaluate new opportunities for targeted therapies and other cancer treatments. This research examines the awareness and ...  |  more...
$10,000.00
Chinese Markets for Drug Delivery System
11/1/2012 | published by: Asia Market Information & Development Company
... trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2001, 2006 and 2011) and long-term forecasts through 2016 and 2021 are presented. Major producers ...  |  more...
$4,000.00
Smart Pills Technologies Market (2012-2017) (Diagnostic imaging, patient monitoring, drug delivery)
10/26/2012 | published by: MarketsandMarkets
... GI disorders are still an enigma to the medical industry due to lack of effective medical devices that reach the contours of small intestine. Although there are flexible endoscopes, they still cause discomfort to the ...  |  more...
$4,650.00
Global Drug-eluting Stents Market 2011-2015
10/1/2012 | published by: Infiniti Research Limited
... market has also been witnessing the use of bifurcated self-expanding coronary stents. However, the decline in the average selling price of drug-eluting stents could pose a challenge to the growth of this market. TechNavio's report, ...  |  more...
$2,000.00
2009 United States Oncology Drug Delivery Patterns, Preferences, and Opportunities
9/27/2012 | published by: Frost & Sullivan
... identify physicians prescribing trends relative to delivery considerations; understand the role of reimbursement in a physician’s choice of drug delivery; and determine product attributes relative to delivery that are considered important by patients and oncologists. ...  |  more...
$10,000.00
White Paper: Beyond Nicoderm(TM) Transdermal Patches See Growth
9/18/2012 | published by: Kalorama Information
... The World Market for Transdermal Drug Delivery, explains how transdermal patches and other mechanisms of drug delivery through a patient's skin have moved beyond their original smoking cessation product categories into new areas.      |  more...
The World Market for Transdermal Drug Delivery
9/13/2012 | published by: Kalorama Information
... out, including sex hormones and pain management, due to the successful combination of the individual drug molecules and available product technologies. The potential benefits that may be achieved using transdermal delivery include continuous, controlled release ...  |  more...
$2,500.00
Innovations in Drug Delivery - Broad-based Proprietary Technology Platforms to Address Delivery Efficiency and Improve Patient Compliance
9/11/2012 | published by: GBI Research
... Broad-based Proprietary Technology Platforms to Address Delivery Efficiency and Improve Patient Compliance”. The report provides an overview of the most exciting innovations in drug delivery technologies in major therapeutic areas – oncology, vaccines, diabetes, rheumatology ...  |  more...
$3,500.00
Nanoparticles in Biotechnology, Drug Development and Drug Delivery
9/1/2012 | published by: BCC Research
... billion in 2017 after increasing at a five-year compound annual growth rate (CAGR) of 19.9%. Drug delivery systems are expected to increase from $11.3 billion in 2012 to $30.9 billion in 2017, a CAGR of ...  |  more...
$5,450.00
Injectable Drug Delivery to 2016 Drugs, Devices, Targets, Therapeutics and Forecasts
9/1/2012 | published by: Greystone Research Associates
... levels of the healthcare sector. The injectable drug segment has seen a marked increase in the level of drug/device integration, as prefilled syringes and specialized injection devices proliferate in response to safety and economic challenges ...  |  more...
$4,850.00
U.S. Market for Diabetes Monitoring, Treatment and Drug Delivery
7/1/2012 | published by: iData Research, Inc.
... glucose test strips, lancets and lancing devices, insulin, insulin syringes, insulin pens and insulin pumps Market growth is expected to be fueled by an increasing number of diabetics and improved education regarding the importance of ...  |  more...
$7,495.00
Intranasal Drug Delivery
5/1/2012 | published by: Global Industry Analysts
... 2017. Also, a six-year historic analysis is provided for this market. The report profiles 71 companies including many key and niche players such as Aegis Therapeutics LLC, Alza Corporation, AptarGroup, Inc., Archimedes Pharma Limited., AstraZeneca ...  |  more...
$4,500.00
U.S. Market for Diabetes Monitoring, Treatment and Drug Delivery 2012
5/1/2012 | published by: iData Research, Inc.
... glucose test strips, lancets and lancing devices, insulin, insulin syringes, insulin pens and insulin pumps Market growth is expected to be fueled by an increasing number of diabetics and improved education regarding the importance of ...  |  more...
$7,495.00
Oral Drug Delivery Market to 2017 - Out-licensing Proprietary Technologies for Proteins, Peptides and Small Molecules to Drive Revenue Growth
4/30/2012 | published by: GBI Research
... Delivery Market to 2017 - Out-licensing Proprietary Technologies for Proteins, Peptides and Small Molecules to Drive Revenue Growth”. The report focuses on the current scenario of orally administered drugs. Key segment of orally administered drugs ...  |  more...
$3,500.00
Herpes Market to 2018 - Genericization Compels Competitors Seeking Differentiation to Adopt Novel Drug Delivery Technologies
4/1/2012 | published by: GBI Research
... Technologies finds that the global herpes market is an attractive one, and is expected to witness growth during the forecast period and to provide good opportunities for investors. The expected high growth is attributed to ...  |  more...
$3,500.00
Freedonia Focus on Implantable Medical Devices: United States
3/31/2012 | published by: Freedonia Focus
... environment, product and procedure forecasts, industry composition and industry leaders. Product segments include orthopedic, cardiac and other implants; procedures include orthopedic, cardiovascular and other procedures. This 18 page report also includes a highlights summary and ...  |  more...
$600.00
Drug Delivery Partnership Strategies
3/5/2012 | published by: Business Insights
... Features and benefits Learn from interviews with senior drug delivery partnering executives. Develop effective partnering strategies based on case studies and analysis of market data. Unlock therapeutic value of new biopharmaceutical developments by strategic collaborations ...  |  more...
$3,835.00
Implantable Medical Devices
3/1/2012 | published by: Freedonia Group Inc
... expected to be strong over the forecast period. Next generation devices have increased confidence in orthopedic, cardiovascular and other implants. Demand will also benefit from the lack of alternative treatments for many chronic disorders and ...  |  more...
$5,100.00
Global Inhaled Antibiotics Market 2011-2015
2/29/2012 | published by: Infiniti Research Limited
... Inhaled Antibiotics market has also been witnessing the trend of huge investment in R&D of drugs by the vendors. However, the high cost of inhaled antibiotics could pose a challenge to the growth of this ...  |  more...
$1,500.00
Drug Delivery: Surveying the Global Competitive Landscape
2/9/2012 | published by: Espicom Healthcare Intelligence
... exciting development companies with novel drug delivery technologies Find out more about the competitive environment Profile the leading drug delivery companies as they battle for supremacy Understand the trends that are driving the sector onwards  |  more...
$1,040.00
Nanotechnology for Drug Delivery: Global Market for Nanocarriers
2/7/2012 | published by: Cientifica Ltd.
... nanocarriers respectively, although developing new targeted delivery mechanisms may allow more value to be created for companies and entrepreneurs. Of the 10 nanocarrier technologies studied, liposomes and gold nanocarriers account for 45% of the total ...  |  more...
$1,599.00
Needle Array Drug Delivery Systems
2/1/2012 | published by: Greystone Research Associates
... and by the need for safer, more reliable drug products that improve compliance. For drugs designed to be delivered across the skin, needle arrays are viewed as an approach that addresses these key healthcare objectives. ...  |  more...
$2,850.00
Drug Delivery Technologies: Commercial Prospects 2012-2022
1/31/2012 | published by: Visiongain
... commercial opportunities for improved drug delivery exist. You discover sales predictions to 2022 at world market, submarket, application and national level. In particular, our report forecasts six submarkets to 2022, showing you potential revenues: Oral ...  |  more...
$2,739.00
Freedonia Focus on Drug Delivery Products: United States
1/31/2012 | published by: Freedonia Focus
... and global overview, market environment, product and application forecasts, industry composition and leading participants. Product segments include oral, parenteral and other drug delivery products; application segments cover central nervous system (CNS), respiratory, hormones and related, ...  |  more...
$600.00
Dosing And Dispensing Drives Home And Personal Care Closures
1/23/2012 | published by: Euromonitor International
... Adding such value is especially important in mature developed economies, where growth is increasingly hard to come by. Nevertheless, plastic dispensing closures will still account for most growth, with emerging regions and BRIC countries to ...  |  more...
$2,000.00
< prev 1  2  3  4  5  6  7  8  9  10  next >